ALLO
Allogene Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:59:54 PM EST
0.84USD+1.439%(+0.01)11,661,001
Pre-marketNov 13, 2026 9:12:30 AM EST
0.8479USD+2.527%(+0.0209)
After-hoursNov 13, 2026 4:37:30 PM EST
0.8301USD-1.049%(-0.0088)
ALLO Financials
In Q3 FY 2026 (ended ), Allogene Therapeutics, Inc. Common Stock (ALLO) reported revenue of $0, net income of −$50.37M, operating cash flow of −$36.12M, and assets of $511.32M (filed ).
Loading financial statements…